Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.
CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA.
52 Week High
52 Week Low
Why CRISPR Therapeutics Stock Is Tumbling Today
CRISPR Therapeutics AG (NASDAQ: CRSP) is trading lower Wednesday after the company reported results from its Phase 1 CARBON trial of CTX110 in relapsed or refra
— per share
Expected Oct 28, After Hours